Active ingredient
Durvalumab NDC Codes
Durvalumab is an active ingredient in 2 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Imfinzi
- Labelers
- AstraZeneca Pharmaceuticals LP
- Strengths
- Durvalumab 120 mg/2.4mL; Durvalumab 500 mg/10mL
- Dosage forms
- Injection, Solution
- Routes
- Intravenous
- Drug classes (FDA established)
- Programmed Death Ligand-1 Blocker
- HCPCS / J-code
- J9173 — Injection, durvalumab, 10 mg
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Imfinzidurvalumab | Durvalumab 120 mg/2.4mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4500 | 00310-4500-12 | J9173 |
| Imfinzidurvalumab | Durvalumab 500 mg/10mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4611 | 00310-4611-50 | J9173 |
Durvalumab: common questions
- Which drugs contain Durvalumab?
- Imfinzi.
- Is there a J-code for Durvalumab?
- Med-Code's HCPCS directory matches J9173 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.